e-learning
resources
Courses
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NSCLC management
R. Huber (Munich, Germany)
Source:
ERS Skills Course 2016
Number:
9
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Huber (Munich, Germany). NSCLC management. ERS Skills Course 2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
NSCLC/SCLC diagnosis and staging of thoracic tumours
Mediastinal tumours
Mesothelioma
Related content which might interest you:
SCLC management
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
SCLC management
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
SCLC management
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
Year: 2019
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013
The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Results of surgical treatment in elderly patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002
Towards personalized treatment in non-small-cell lung carcinoma
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020
Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007
Treatment of advanced non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006
Therapeutic management of ALK+ nonsmall cell lung cancer patients
Source: Eur Respir J 2015; 46: 230-242
Year: 2015
Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011
Management of patients with non-small-cell lung cancer
Source: ERS Live 2007
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept